By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
May 12, 2023/Review
The new resource, designed specifically for PTs and PTAs, includes evidence-based and best-practice recommendations.
Apr 1, 2021/CPG
This guideline from the Academy of Neurologic Physical Therapy provides evidence on the effects of ankle-foot orthoses and functional electrical stimulation post-stroke.
Apr 30, 2024/Podcast
Recommendations, tips for implementation, and more.
Feb 20, 2018/CPG
This guideline provides recommendations on the management of adults with type 2 diabetes in the primary care setting.
Mar 23, 2021/CPG
Recommendations for managing COVID‑19 symptoms for patients in the community -- babies, children, young people, and adults in all care settings, including at the end of life.
Nov 11, 2021/CPG
This "living" guideline covers identifying, assessing, and managing the long-term effects of COVID-19, frequently described as "long COVID." It makes recommendations about care in all health care settings for adults, children, and young people who have new or ongoing symptoms lasting four weeks or more
Dec 1, 2024/CPG
This revised guideline from the Academy of Orthopaedic Physical Therapy of the American Physical Therapy Association provides updated recommendations to support evidence-based practice, including tailored clinical decision-making, about managing Achilles tendinopathy. This guideline does not include
Jun 1, 2025/CPG
CPG+ Appraisal Rating 7 out of 7 (How is this rating made?) Highlights Three core outcome measures (COMS) related to physical function should be performed for all adult patients receiving physical therapy during a hospital stay. (p 3) Five supplemental outcome measures (OMs) may be added to augment COMS.
Feb 1, 2020/CPG
Directions for clinicians and patients making treatment decisions for the management of OA.
Oct 3, 2025/CPG
This evidence-based care guideline from Cincinnati Children’s Hospital provides recommendations for therapeutic management of pediatric and adolescent joint hypermobility and hypermobility spectrum disorder, including hypermobile Ehlers-Danlos syndrome. It does not address children and adolescents with